Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Ca… (NCT01764789) | Clinical Trial Compass
CompletedNot Applicable
Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer
United States39 participantsStarted 2010-10
Plain-language summary
This pilot clinical trial studies stress reduction in improving quality of life in patients with recurrent gynecologic or breast cancer. Participating in a stress reduction program may help improve quality of life in patients with gynecologic or breast cancer.
Who can participate
Age range21 Years – 85 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Diagnosis of recurrent breast or gynecologic cancer (any site) with any disease-free interval; second primary cancers do not meet this criterion
* English speaking
* Able and willing to give informed consent
* To be considered for the blood and saliva collection, women must fulfill the following secondary criteria:
* Diagnosis of recurrent breast or ovarian cancer with any disease-free interval
Exclusion Criteria:
* Residence \> 70 miles from research site
* Subnormal intellectual potential (diagnosis of mental retardation)
* Progressive neurological or chronic, progressive, debilitating condition (e.g., dementia)
* Non-ambulatory
* Life expectancy less than 160 days, per the treating oncologist
* Current suicide risk sufficient to preclude treatment on an outpatient basis
* Chronic inflammatory or autoimmune disorder (e.g., rheumatoid arthritis, lupus)
What they're measuring
1
Quality of life(QoL)
Timeframe: up to 28 weeks
Trial details
NCT IDNCT01764789
SponsorOhio State University Comprehensive Cancer Center